Thornton is based in Cambridge and reports to director of corporate affairs Anna Sörman, who only recently joined Amgen in a newly created role (PRWeek, 16 September). Sörman formerly worked at Sanofi-Aventis.
Amgen, headquartered in California, is behind drugs including psoriasis treatment Enbrel and Aranesp, a treatment for kidney-
disease-related and chemotherapy-induced anaemia.
At Syngenta, a company at the heart of the debate on genetically modified crops, Thornton was head of UK comms and marketing support for its crop protection business, a job also based
Syngenta was created five years ago through the merger of the agrochemicals and seeds activities of Swiss firm Novartis and AstraZeneca.